Showing results (1-10 of 191) with videos related to
Sort By:
Pageof 20
Journal of Clinical Pathology|February 28, 2024
Gene of the month: the uroplakinsKrithicck Sivakumaar, Jon Griffin, Ella Schofield, et al.Journal of Clinical Pathology|January 8, 2022
Gene of the month: NKX3.1Jon Griffin, Yuqing Chen, James W F Catto, et al.European Urology Focus|June 25, 2019
Is Social Media Worth the Risk for Health Care Professionals?James W F CattoPlos One|October 21, 2020
Occupational bladder cancer: A cross section survey of previous employments, tasks and exposures matched to cancer phenotypesOliver Reed, Ibrahim Jubber, Jon Griffin, et al.Methods in Molecular Biology (Clifton, N.J.)|October 9, 2010
Epigenetic regulation of microRNA expression in cancerHani Choudhry, James W F CattoExpert Review of Anticancer Therapy|February 10, 2012
Molecular mechanisms of cisplatin resistance in bladder cancerRoss M Drayton, James W F CattoCurrent Opinion in Urology|July 23, 2014
Noncoding RNA in bladder cancer: a specific focus upon high-risk nonmuscle invasive diseaseAidan P Noon, James W F CattoWorld Journal of Urology|September 19, 2012
Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumoursDavid R Yates, James W F CattoFuture Oncology (London, England)|February 12, 2010
Targeting chemotherapy to advanced bladder cancer patients most likely to benefitJames W F Catto, Freddie C HamdyEuropean Urology Oncology|September 5, 2019
How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?Shahrokh Shariat, Paolo Gontero, James W F CattoPageof 20